QSAR and molecular docking studies on non-imidazole-based histamine h3 receptor antagonists

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Background: In the recent years, histamine H3 receptor (H3R) has been receiving increasing attention in pharmacotherapy of neurological disorders. The aim of the current study was to investigate structural requirements for the prediction of H3 antagonistic activity using quantitative structure-Activity relationship (QSAR) and molecular docking techniques. Methods: To this end, genetic algorithm coupled partial least square and stepwise multiple linear regression methods were employed for developing a QSAR model. The obtained QSAR model was stringently assessed using different validation criteria. Results: The generated model indicated that connectivity information and mean absolute charge are two important descriptors for the prediction of H3 antagonistic activity of the studied compounds. To gain insight into the mechanism of interaction between studied molecules and H3R, molecular docking was performed. The most important residues involved in the ligandreceptor interactions were identified. Conclusion: The result of current study can be used for designing of new H3 antagonist and proposing structural modifications to improve H3 inhibitory potency.

Cite

CITATION STYLE

APA

Hamzeh-Mivehroud, M., Khoshravan-Azar, Z., & Dastmalchi, S. (2020). QSAR and molecular docking studies on non-imidazole-based histamine h3 receptor antagonists. Pharmaceutical Sciences, 26(2), 165–174. https://doi.org/10.34172/PS.2019.64

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free